Last slide of the presentation.
Near term milestones.
Clinical update April.
Full, unblinded results 6-8 weeks from the presentation in Q2.
David doubled down on the 6-8 week guideline and its bamboozled a few of us.
Ann: ISLA-101 shows anti-dengue activity in Phase 2a readout, page-205
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 13.5¢ | $5.006K | 36.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10195 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 56381 | 2 |
View Market Depth
| Last trade - 12.13pm 24/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |